New Zealand markets open in 1 hour 15 minutes
  • NZX 50

    -90.11 (-0.82%)

    +0.0023 (+0.37%)

    -131.40 (-1.91%)
  • OIL

    -3.86 (-3.52%)
  • GOLD

    -9.60 (-0.53%)

Global Contrast Media Injectors (Single Head, Dual Head) Market Analysis Report 2022-2030: Increasing Usage of Consumables for Several Diagnostic Procedures -

·3-min read

DUBLIN, May 24, 2022--(BUSINESS WIRE)--The "Contrast Media Injectors Market Size, Share & Trends Analysis Report by Product (Injector Systems, Consumables), by Type (Single Head, Dual Head), by Application, by End Use, by Region, and Segment Forecasts, 2022-2030" report has been added to's offering.

The global contrast media injectors market is expected to reach USD 1.65 billion by 2030, registering a CAGR of 4.83%

The market is expected to grow because of the rising demand for minimally invasive surgical procedures, along with the increasing usage of consumables for several diagnostic procedures, which are supporting the market growth of contrast media injectors.

COVID-19 had a significant impact on the contrast media injector market, in 2019, with around a 30-40% reduction in sales due to the imposed lockdown and rapid decline in imaging case volume.

However, the market is expected to return to peak levels of 2019 by 2022. This is due to the launch of COVID-19 vaccines and ease in restrictions, import & export of raw materials have resumed; therefore, the market is expected to grow at a significant rate over the forecast period.

Technological advancements such as IT-enabled solutions for contrast media injectors, along with growing demand for minimally invasive surgical procedures, are expected to boost the market during the coming years. Furthermore, the large number of intraoperative imaging procedures being performed has further enhanced the demand for these injectors, propelling the market growth.

Contrast Media Injectors Market Report Highlights

  • by product, injector systems accounted for the largest market share of 61.33% in 2021, due to its growing application in the diagnosis and treatment of vascular disease, cancer, and others.

  • by type, single head injectors accounted for the largest market share of 44.44% in 2021, because of their wide usage in the field of angiography, CT, and MRI as well these products are inexpensive.

  • Based on the application, the radiology segment dominated the market with around 47.39% of the revenue share in 2021, because it is the primary procedure used for the diagnosis of several chronic diseases.

  • Based on the end use, the hospitals segment dominated the market with around 68.07% of the revenue share in 2021, due to the fact that these facilities are primary users of the contrast media injectors because of their need to record the rhythm & electrical activity and evaluate the results in detail for clinical & research purposes.

  • Asia Pacific contrast media injectors market is expected to witness the fastest growth rate at a CAGR of 5.41% over the forecast period. Factors that can be attributed to market growth include the growing geriatric population and an increasing number of surgeries.

Market Dynamics

Market Driver Analysis

  • Increasing demand for minimally invasive surgeries

  • Increasing application in neurosurgeries and orthopedic surgeries

  • Technological advancement in contrast media injectors

  • Growing Number Of Regulatory Approvals

Market Restraints Analysis

  • Prolonged Approval Process

  • High Cost Of Contrast Media Injectors

Contrast Media Injectors: Market Analysis Tools

  • Industry Analysis - Porter's Five Forces Analysis

  • SWOT Analysis, by PEST

Impact of COVID-19 on Market& Post Pandemic Insights

Competitive Analysis

Company Categorization

  • Innovators

  • Market Leaders

Vendor Landscape

  • Key Company Market Share Analysis, 2021

  • Major Deals and Strategic Alliances

  • New Product Launch

  • Expansion

  • Acquisition

  • Market Entry Strategies

Company Profiles

  • Bayer Healthcare LLC

  • Bracco Group

  • Ulrich Medical

  • Guerbet Group

  • Medtron AG

  • Nemoto Kyorindo Co. Ltd.

  • Hong Kong Medi Co Limited

For more information about this report visit

View source version on

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting